Clinical Trials Logo

Clinical Trial Summary

It is proposed to measure sperm DNA damage by sperm chromatin dispersion test. This measurement helps to better diagnose male infertility and seems easy to apply in routine. However, the reliability of this method needs to be evaluated before applying for clinical practice in andrology laboratory.


Clinical Trial Description

The aim of this study is to measure the inter and intra-observer reliability for the measurements of sperm DNA damage by sperm chromatin dispersion test (halosperm). The gold standard to measure sperm DNA damage is TUNEL (Terminal desoxynucleotidyl end labelling) method. However, this method is not easy to apply in routine. Therefore we investigate to analyse the inter-method reliability between sperm chromatin dispersion test and TUNEL. ;


Study Design

Time Perspective: Prospective


Related Conditions & MeSH terms


NCT number NCT02252510
Study type Observational
Source University Hospital, Clermont-Ferrand
Contact
Status Completed
Phase N/A
Start date January 2013
Completion date June 2014

See also
  Status Clinical Trial Phase
Recruiting NCT04941690 - Erectile Dysfunction, Psychological Disorders, and Sexual Performance Among Men Seeking Medical Help for Fertility